G01N 2333/90672
With oxygen as acceptor in general
Official title: with oxygen as acceptor (1.5.3) in general
G01N2333/90672 (With oxygen as acceptor in general) appears on 20 US grants and 28 published applications in this corpus.
Search patents in G01N- Granted patents
- 20
- Published applications
- 28
- Assignees
- 14
- Inventors
- 43
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 6 |
| 2017 | 1 | 8 |
| 2018 | 3 | 3 |
| 2019 | 1 | 0 |
| 2020 | 3 | 3 |
| 2021 | 3 | 1 |
| 2022 | 1 | 1 |
| 2023 | 2 | 0 |
| 2024 | 2 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Analyte sensors and sensing methods for detecting creatinine28 Jul 2026US 12,693,255 B2Abbott Diabetes Care Inc.
- Glycated hemoglobin oxidase variant and method for measurement25 Mar 2025US 12,258,589 B2Kikkoman Corporation
- Method for calibrating a device for measuring the concentration of creatinine23 Apr 2024US 11,965,854 B2Radiometer Medical ApS
- Method for calibrating a device for measuring the concentration of creatinine16 Jan 2024US 11,874,285 B2Radiometer Medical ApS
- Systems and methods for sample preparation for enzymatic A1C detection and quantification25 Apr 2023US 11,634,745 B2Polymer Technology Systems, Inc.
- Analyte sensors and sensing methods for detecting creatinine8 Oct 2026US 2026/0309669 A1Abbott Diabetes Care Inc.
- Method for calibrating a device for measuring the concentration of creatinine11 Jul 2024US 2024/0230578 A1Radiometer Medical ApS
- Method for calibrating a device for measuring the concentration of creatinine14 Apr 2022US 2022/0113274 A1Radiometer Medical ApS
- Method for the in vitro diagnosis of prostate cancer by means of urinary biomarkers2 Sep 2021US 2021/0270836 A1Nib Biotec S.R.L.
- Glycated hemoglobin oxidase variant and method for measurement10 Sep 2020US 2020/0283741 A1Kikkoman Corporation
Most cited
By later US patents
- Biosensor with improved interference characteristics3US 9,562,874 B2Abbott Point of Care Inc. · 2017
- Eukaryotic amadoriase having excellent thermal stability, gene and recombinant DNA for the eukaryotic amadoriase, and process for production of eukaryotic amadoriase having excellent thermal stability2US 8,003,359 B2Kikkoman Corporation · 2011
- Modified amadoriase and method for producing the same, agent for improving surfactant resistance of amadoriase and composition for measuring HbA1c using the same1US 10,619,183 B2Kikkoman Corporation · 2020
- Modified amadoriase reacting with fructosyl hexapeptide1US 10,767,211 B2Kikkoman Corporation · 2020
- Method for calibrating a device for measuring the concentration of creatinine1US 11,874,285 B2Radiometer Medical ApS · 2024